Stay updated on Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Sign up to get notified when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added the Locations section with the Gyeonggi-do site (Seongnam-si, South Korea) and updated the revision to v3.3.3. Removed the Gyeonggi-do Locations header and the HHS Vulnerability Disclosure link in this update.
    Difference
    0.2%
    Check dated 2025-12-23T17:17:11.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    The page shows an updated revision note (Revision: v3.3.2) and the previous revision (Revision: v3.2.0) has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T16:53:24.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Removed the government funding notice banner that warned about potential delays and updates.
    Difference
    0.4%
    Check dated 2025-11-17T14:59:34.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    Added related topics 'Type 2 diabetes' and 'MedlinePlus Genetics' to the study page.
    Difference
    0.6%
    Check dated 2025-11-03T01:29:00.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The page no longer displays the condition 'Type 2 diabetes' and the related topic 'MedlinePlus Genetics'. This reduces visibility of the study's focus and related resources for users.
    Difference
    0.2%
    Check dated 2025-10-26T20:49:59.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic covering Type 2 diabetes, expanding core content.
    Difference
    0.3%
    Check dated 2025-10-12T14:45:42.000Z thumbnail image

Stay in the know with updates to Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipragliflozin vs Sitagliptin in T2DM with SU+Met Clinical Trial page.